Orient EuroPharma (4120.TWO) Earnings Analysis
Orient EuroPharma (4120.TWO) has no confirmed upcoming earnings date. Trailing P/E -9.07.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4120.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4120.TWO. This page updates as the calendar is published.
4120.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | -0.53 TWD | n/a | n/a | n/a |
| 2024-12-31 | -1.55512 TWD | n/a | n/a | n/a |
| 2024-09-30 | 0.13 TWD | n/a | n/a | n/a |
4120.TWO valuation and analyst view
| Trailing P/E | -9.07 |
|---|---|
| Trailing EPS | -4.62576 TWD |
| Price / book | 0.70 |
| Dividend yield | 8.70% |
| Market cap | 3.98B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Orient EuroPharma (4120.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4120.TWO. This page updates as the calendar is published.
Did 4120.TWO beat earnings last quarter?
Consensus estimate data was not available for 4120.TWO's 2025-06-30 report.
What is 4120.TWO's current P/E ratio and EPS?
4120.TWO trades at a trailing P/E of -9.07 on trailing EPS of -4.625762274199684 TWD.
What do analysts rate 4120.TWO?
4120.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.